Ameriprise’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
412,311
+134,963
| +49% | +$459K | ﹤0.01% | 3101 |
|
|
2025
Q1 | $1.11M | Buy |
277,348
+27,980
| +11% | +$112K | ﹤0.01% | 3143 |
|
|
2024
Q4 | $1.62M | Sell |
249,368
-104,073
| -29% | -$675K | ﹤0.01% | 3014 |
|
|
2024
Q3 | $1.96M | Buy |
353,441
+85,805
| +32% | +$475K | ﹤0.01% | 2921 |
|
|
2024
Q2 | $1.49M | Sell |
267,636
-21,920
| -8% | -$122K | ﹤0.01% | 2995 |
|
|
2024
Q1 | $1.94M | Sell |
289,556
-10,196
| -3% | -$68.4K | ﹤0.01% | 2885 |
|
|
2023
Q4 | $2.73M | Sell |
299,752
-17,571
| -6% | -$160K | ﹤0.01% | 2713 |
|
|
2023
Q3 | $1.75M | Sell |
317,323
-286,838
| -47% | -$1.58M | ﹤0.01% | 2881 |
|
|
2023
Q2 | $5.16M | Buy |
604,161
+347,911
| +136% | +$2.97M | ﹤0.01% | 2324 |
|
|
2023
Q1 | $2.35M | Buy |
256,250
+373
| +0.1% | +$3.43K | ﹤0.01% | 2765 |
|
|
2022
Q4 | $2.61M | Sell |
255,877
-28,074
| -10% | -$286K | ﹤0.01% | 2694 |
|
|
2022
Q3 | $4.18M | Buy |
283,951
+7,749
| +3% | +$114K | ﹤0.01% | 2348 |
|
|
2022
Q2 | $2.96M | Buy |
+276,202
| New | +$2.96M | ﹤0.01% | 2619 |
|
|
2021
Q4 | – | Sell |
-87,634
| Closed | -$1.88M | – | 3972 |
|
|
2021
Q3 | $1.88M | Buy |
+87,634
| New | +$1.88M | ﹤0.01% | 2895 |
|